Skip to main content Skip to section navigation Skip to footer
Stock Information
chevron_left Back to CastleBiosciences.com
Castle Biosciences, Inc. IR Home
  • Overview
  • News & Events keyboard_arrow_down
    • Press Releases
    • IR Events
    • Presentations
    • In The Media
    • Annual Meeting
    • Email Alerts
  • Company Info keyboard_arrow_down
    • Company Profile
    • Executive Team
    • Annual Reports & Proxy
    • Contacts
    • FAQ
  • Financial Info keyboard_arrow_down
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data keyboard_arrow_down
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings keyboard_arrow_down
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance keyboard_arrow_down
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Corporate Responsibility
  • Resources keyboard_arrow_down
    • Scientific Evidence
  • Stock Information
  • chevron_leftBack to CastleBiosciences.com

In The Media

News & Events

  • Press Releases
  • IR Events
  • Presentations
  • In The Media
  • Annual Meeting
  • Email Alerts
Oct 30, 2022
Dermatology Times: One Test Helps Inform Two Key Clinical Decisions in the Management of Melanoma
Oct 22, 2022
Dermatology Times: How Mohs Surgeons Use Prognostic Testing for High-Risk SCC
Oct 19, 2022
Cancer Network: TissueCypher Barrett’s Esophagus Test Increases Risk Assessment Accuracy in High-Grade Dysplasia/Esophageal Adenocarcinoma
Sep 5, 2022
Arizona Business Magazine: Making People a Priority
Sep 1, 2022
PracticeLink: DecisionDx-Melanoma for Precise Melanoma Management
Sep 1, 2022
Skin Cancer Foundation: Emerging Technologies for High-Risk Skin Cancers: Tools for Informed Decision Making
Aug 17, 2022
PracticeUpdate: Optimizing Treatment for Patients with Cutaneous Melanoma
Jul 22, 2022
AZCentral: Top Workplaces Surveys Companies to Rank Arizona's Top Employers
Jul 7, 2022
Genetic Engineering and Biotechnology News (GEN): Anti-Inflammatory Drugs Demonstrate Pathway Savvy
May 26, 2022
NBC4: Today in LA - Skin Cancer Awareness Month
rss_feed RSS
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Next Pagearrow_forward
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
©2026 Castle Biosciences, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement

Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.